Stay updated on Arbaclofen in Children and Adolescents With ASD Clinical Trial
Sign up to get notified when there's something new on the Arbaclofen in Children and Adolescents With ASD Clinical Trial page.

Latest updates to the Arbaclofen in Children and Adolescents With ASD Clinical Trial page
- CheckyesterdayChange DetectedThe footer site revision changes from v3.7.0 to v3.7.1 on the 403 Forbidden page.SummaryDifference0.2%

- Check8 days agoNo Change Detected
- Check15 days agoNo Change Detected
- Check22 days agoChange DetectedThe page now shows a 403 Forbidden error with minimal navigation (e.g., Home and Revision information), replacing the previous detailed study content and related metadata.SummaryDifference21%

- Check43 days agoChange DetectedThe page now displays a new revision tag, v3.6.6, replacing the previous v3.6.5, representing a minor internal update to the study details page.SummaryDifference0.0%

- Check50 days agoChange DetectedA note indicating NIH funding for 2018 was added, reflecting NIH support for the study.SummaryDifference0.0%

- Check65 days agoChange DetectedA new site entry, Hospital General Universitario Gregorio Marañon, was added to the study locations (non-accented form) and the accented version Hospital General Universitario Gregorio Marañón was removed. The revision tag was updated from v3.6.4 to v3.6.5.SummaryDifference0.1%

- Check79 days agoChange DetectedThe page revision label was updated from v3.6.3 to v3.6.4, indicating an internal update to the page. There are no changes to the study content or user-facing information.SummaryDifference0.0%

Stay in the know with updates to Arbaclofen in Children and Adolescents With ASD Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Arbaclofen in Children and Adolescents With ASD Clinical Trial page.